文献速递神经MRPET

转移性脑肿瘤患者中治疗所致坏死与复发肿瘤的鉴别:11C-蛋氨酸-PET、FDG-PET、MR渗透性成像与MRI-ADC的初步比较

Differentiation between Treatment-Induced Necrosis and Recurrent Tumors in Patients with Metastatic Brain Tumors: Comparison among 11C-Methionine-PET, FDG-PET, MR Permeability Imaging, and MRI-ADC-Preliminary Results.
PubMed 文献 · AJNR Am J Neuroradiol · 2017-06-15

本研究分析15例转移性脑肿瘤患者伽玛刀放射外科术后的18个病灶(其中10个经手术证实为复发肿瘤),比较11C-蛋氨酸PET、FDG-PET、MR渗透性成像及DWI-ADC在鉴别放射性坏死与复发肿瘤中的价值。结果显示11C-蛋氨酸比值的ROC曲线下面积最高(0.90),其次为对比增强率(0.81)、最大上升斜率(0.80)、初始曲线下面积(0.78)等,FDG比值最低(0.53)。作者认为11C-蛋氨酸PET可能优于MR渗透性成像、ADC及FDG-PET。

要点

  • 11C-蛋氨酸比值鉴别放射性坏死与复发肿瘤的AUC为0.90,为各指标中最高。
  • 对比增强率AUC 0.81、最大上升斜率AUC 0.80、初始曲线下面积AUC 0.78。
  • FDG比值AUC仅0.53,鉴别能力最低。

核心结论

  • 本研究提示,对于转移性脑肿瘤伽玛刀放射外科术后,11C-蛋氨酸PET在鉴别放射性坏死与复发肿瘤方面可能优于MR渗透性成像、ADC和FDG-PET。

研究设计与样本

  • 研究分析了15例接受伽玛刀放射外科治疗的转移性脑肿瘤患者的18个病灶,其中10个病灶经手术证实为复发肿瘤;计算MR渗透性成像各参数并获取ADC,测量11C-蛋氨酸PET与FDG-PET的病灶最大标准化摄取值与对侧大脑半球对称部位最大标准化摄取值之比,采用受试者工作特征曲线分析。

诊断标准与关键数值

  • 鉴别放射性坏死与复发肿瘤的AUC:11C-蛋氨酸比值0.90、对比增强率0.81、最大上升斜率0.80、初始信号强度-时间曲线下面积0.78、血浆分数容积0.76、对比剂到达时间0.76、血管内与血管外细胞外间隙间转运常数0.74、血管外细胞外间隙0.68、最小ADC 0.60、血管外细胞外间隙至血浆转运常数0.55、FDG比值0.53。

临床应用与阅片要点

  • 11C-蛋氨酸比值、对比增强率、最大上升斜率和初始信号强度-时间曲线下面积在放射性坏死与复发肿瘤间差异显著(分别为P < .01、P < .01、P < .05、P < .05)。

局限性

  • 原文标题标明为初步结果(Preliminary Results)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: In patients with metastatic brain tumors after gamma knife radiosurgery, the superiority of PET using 11C-methionine for differentiating radiation necrosis and recurrent tumors has been accepted. To evaluate the feasibility of MR permeability imaging, it was compared with PET using 11C-methionine, FDG-PET, and DWI for differentiating radiation necrosis from recurrent tumors.

MATERIALS AND METHODS: The study analyzed 18 lesions from 15 patients with metastatic brain tumors who underwent gamma knife radiosurgery. Ten lesions were identified as recurrent tumors by an operation. In MR permeability imaging, the transfer constant between intra- and extravascular extracellular spaces (/minute), extravascular extracellular space, the transfer constant from the extravascular extracellular space to plasma (/minute), the initial area under the signal intensity-time curve, contrast-enhancement ratio, bolus arrival time (seconds), maximum slope of increase (millimole/second), and fractional plasma volume were calculated. ADC was also acquired. On both PET using 11C-methionine and FDG-PET, the ratio of the maximum standard uptake value of the lesion divided by the maximum standard uptake value of the symmetric site in the contralateral cerebral hemisphere was measured (11C-methionine ratio and FDG ratio, respectively). The receiver operating characteristic curve was used for analysis.

RESULTS: The area under the receiver operating characteristic curve for differentiating radiation necrosis from recurrent tumors was the best for the 11C-methionine ratio (0.90) followed by the contrast-enhancement ratio (0.81), maximum slope of increase (millimole/second) (0.80), the initial area under the signal intensity-time curve (0.78), fractional plasma volume (0.76), bolus arrival time (seconds) (0.76), the transfer constant between intra- and extravascular extracellular spaces (/minute) (0.74), extravascular extracellular space (0.68), minimum ADC (0.60), the transfer constant from the extravascular extracellular space to plasma (/minute) (0.55), and the FDG-ratio (0.53). A significant difference in the 11C-methionine ratio (P < .01), contrast-enhancement ratio (P < .01), maximum slope of increase (millimole/second) (P < .05), and the initial area under the signal intensity-time curve (P < .05) was evident between radiation necrosis and recurrent tumor.

CONCLUSIONS: The present study suggests that PET using 11C-methionine may be superior to MR permeability imaging, ADC, and FDG-PET for differentiating radiation necrosis from recurrent tumors after gamma knife radiosurgery for metastatic brain tumors.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Tomura N, Kokubun M, Saginoya T, et al. Differentiation between Treatment-Induced Necrosis and Recurrent Tumors in Patients with Metastatic Brain Tumors: Comparison among 11C-Methionine-PET, FDG-PET, MR Permeability Imaging, and MRI-ADC-Preliminary Results. AJNR Am J Neuroradiol. 2017. PMID: 28619837. doi:10.3174/ajnr.A5252

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。